ClinicalTrials.gov
ClinicalTrials.gov Menu

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00078195
Recruitment Status : Completed
First Posted : February 20, 2004
Last Update Posted : October 18, 2016
Sponsor:
Collaborator:
Immune Tolerance Network (ITN)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)